11/21/2011 - 3:13pm

Canadian drug maker Valeant Pharmaceuticals International is acquiring an Australian drug maker for up to A$700 million, Valeant said.

11/21/2011 - 3:04pm

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

11/21/2011 - 2:25pm

Perrigo on Monday named Christopher Roop to the post of VP corporate development.

11/21/2011 - 2:07pm

Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

11/21/2011 - 12:59pm

After being unanimously recommended for approval by a Food and Drug Administration panel, the FDA has approved an eye disorder treatment created by Regeneron Pharmaceuticals.

11/18/2011 - 2:12pm

Citi Investment Research & Analysis is projecting that the peak of flu season may occur beyond last season's peak of January/February, a factor that may place a negative drag on retail same-store sales results over first quarter 2012.

11/18/2011 - 11:48am

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

11/17/2011 - 3:53pm

Bristol-Myers Squibb and AstraZeneca presented an analysis Wednesday of 14 clinical trials at the American Heart Association's Scientific Sessions in Orlando, Fla., the companies said.

11/17/2011 - 3:45pm

GlaxoSmithKline announced the results from the first of eight phase-3 clinical trials that examined the efficacy of albiglutide in the treatment of Type 2 diabetes.